BCG re-vaccination
Showing 1 - 25 of 8,275
Latent Tuberculosis Trial in Dourados (BCG)
Not yet recruiting
- Latent Tuberculosis
- BCG
-
Dourados, Mato Grosso Do Sul, BrazilRoberto Oliveira
Sep 13, 2022
BCG Vaccination on Infectious and Immune Mediated Diseases
Enrolling by invitation
- BCG Vaccination Reaction
- +3 more
- BCG
- Placebo vaccine
-
Nijmegen, Gelderland, NetherlandsRadboud university medical center
Oct 25, 2022
Safety, Immunogenicity Trial in Entebbe, Oxford (ChAdOx185A, MVA85A, BCG)
Active, not recruiting
- Safety
- Immunogenicity
- ChAdOx185A
- +2 more
-
Entebbe, Uganda
- +1 more
May 13, 2021
Alzheimer, Late Onset Trial in Jerusalem (BCG vaccine)
Enrolling by invitation
- Alzheimer Disease, Late Onset
- BCG vaccine
-
Jerusalem, IsraelDepartment of Neurology, Hadassah medical Center
Oct 5, 2023
Vaccine Response Impaired Trial in Adelaide (BCG vaccine, Yellow Fever vaccine, Vancomycin Oral Capsule)
Recruiting
- Vaccine Response Impaired
- BCG vaccine
- +3 more
-
Adelaide, South Australia, AustraliaSouth Australian Health and Medical Research Institute
Nov 17, 2023
BCG Vaccination Reaction Trial in Gresik (BCG vial vaccine, BCG ampoule vaccine)
Completed
- BCG Vaccination Reaction
- BCG vial vaccine
- BCG ampoule vaccine
-
Gresik, Jawa Timur, IndonesiaPuskesmas Cerme
Sep 15, 2022
Severe Illness, Septicaemia, Diarrhoea Trial in Kampala (BCG at birth, Control arm: Delayed BCG)
Recruiting
- Severe Illness
- +3 more
- BCG at birth
- Control arm: Delayed BCG
-
Kampala, UgandaHealth Centers in Mukono and Kampala districts
Aug 24, 2022
Infant Mortality, BCG Trial in Bissau (BCG-Denmark 1331 (Statens Serum Institute))
Terminated
- Infant Mortality
- BCG
- BCG-Denmark 1331 (Statens Serum Institute)
-
Bissau, Guinea-BissauBandim Health Project
Feb 3, 2022
HIV-1-infection Trial in Zurich (BCG Vaccine AJVaccines)
Recruiting
- HIV-1-infection
- BCG Vaccine AJVaccines
-
Zurich, SwitzerlandUniversity Hospital Zurich
Jan 28, 2022
Tuberculosis Trial (BNT164a1, BNT614b1, Placebo)
Not yet recruiting
- Tuberculosis
- BNT164a1
- +2 more
- (no location specified)
Jan 18, 2023
BCG Vaccination Reaction, Tuberculosis Trial (GC3107, Intradermal BCG SSI inj.)
Completed
- BCG Vaccination Reaction
- Tuberculosis
- GC3107
- Intradermal BCG SSI inj.
-
Suwon, Korea, Republic of
- +1 more
Oct 31, 2022
Tuberculosis, HIV Trial in South Africa (VPM1002 Vaccine, BCG Vaccine, Placebo)
Not yet recruiting
- Tuberculosis
- HIV Infections
- VPM1002 Vaccine
- +2 more
-
Johannesburg, Gauteng, South Africa
- +8 more
Sep 14, 2022
Respiratory Tract Infections, Covid19 Trial in Netherlands (Bacille Calmette-Guérin (BCG), Placebo)
Completed
- Respiratory Tract Infections
- Covid19
- Bacille Calmette-Guérin (BCG)
- Placebo
-
Amersfoort, Netherlands
- +19 more
Sep 21, 2022
Diabetes, BCG Vaccination Reaction Trial in Bissau (BCG vaccine (two doses, 4 weeks apart), Saline (Two doses, 4 weeks apart))
Not yet recruiting
- Diabetes Mellitus
- BCG Vaccination Reaction
- BCG vaccine (two doses, 4 weeks apart)
- Saline placebo (Two doses, 4 weeks apart)
-
Bissau, Guinea-BissauBandim Health Project
Oct 31, 2022
Coronavirus, Coronavirus Infection, Coronavirus as the Cause of Diseases Classified Elsewhere Trial in Los Angeles, Bryan,
Active, not recruiting
- Coronavirus
- +2 more
- BCG Vaccine
- Placebo Vaccine
-
Los Angeles, California
- +5 more
Oct 18, 2022
COVID-19 Trial in Netherlands (BCG Vaccine, Placebo)
Completed
- COVID-19
- BCG Vaccine
- Placebo
-
Den Bosch, Brabant, Netherlands
- +8 more
Jun 2, 2022
BCG Vaccination Reaction Trial (bcg vaccine)
Not yet recruiting
- BCG Vaccination Reaction
- bcg vaccine
- (no location specified)
Mar 13, 2021
Bladder Cancer, Bladder Urothelial Carcinoma Trial in Toronto (re-TURBT, 6 weeks BCG instillation)
Terminated
- Bladder Cancer
- Bladder Urothelial Carcinoma
- re-TURBT
- 6 weeks BCG instillation
-
Toronto, Ontario, CanadaUniversity Health Network
Apr 12, 2022
Tuberculosis Trial (BNT164a1, BNT614b1, Placebo)
Not yet recruiting
- Tuberculosis
- BNT164a1
- +2 more
- (no location specified)
Sep 8, 2022
Tuberculosis Trial in Chendu (BCG vaccine 1(0.025mg/0.1ml/person), BCG vaccine 2 (0.05mg/0.1ml/person), BCG vaccine
Recruiting
- Tuberculosis
- BCG vaccine 1(0.025mg/0.1ml/person)
- +4 more
-
Chendu, Sichuan, ChinaSichuan Center for Disease Control and Prevention
Sep 1, 2022
BCG Vaccination in Neonates Born to HIV and LTBI Infected and
Completed
- HIV Infections
- +3 more
- RNAseq
-
Chisinau, Moldova, Republic of
- +1 more
Oct 19, 2021
Innate Immunity, Bacille Calmette-Guérin Trial in Bissau (Bacille Calmette-Guerin, BCG solvent)
Completed
- Innate Immunity
- Bacille Calmette-Guérin
- Bacille Calmette-Guerin
- BCG solvent
-
Bissau, Bissau Codex, Guinea-BissauBandim Health Project
Apr 22, 2021
Infection, Hospitalization, Mortality Trial in Athens (Vaccination, Placebo)
Completed
- Infection
- +2 more
- Vaccination
- Placebo
-
Athens, Attiki, Greece4th Department of Internal Medicine, ATTIKON University Hospital
Jan 8, 2021
Vaccine Preventable Disease, Measles, Mother-Infant Interaction Trial in Bissau (BCG vaccine, Measles vaccine, Placebo)
Recruiting
- Vaccine Preventable Disease
- +3 more
- BCG vaccine
- +2 more
-
Bissau, Bissau Codex, Guinea-BissauBandim Health Project
May 23, 2021
Filarial Infections on Tuberculosis Disease and Tuberculosis
Recruiting
- Tuberculosis
- TB treatment according to national guidelines
-
Buea, CameroonUniversity of Buea
Nov 22, 2021